Filing Flows › CTS (CTS) › Q3 2026 › vs Q2 2026
CTS (CTS) Q3 2026 vs Q2 2026 (quarter over quarter)
CTS's revenue rose $4.8M (+3%) from $145M in Q2 2026 to $150M in Q3 2026. Gross margin 42.2% against 41.5% (+0.7 pts).
CTS, Q3 2026: revenue $150M (+5% year over year), operating margin 17.1%, net earnings $17.8M, operating cash flow $43.5M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Gross margin | 42.2% | 41.5% | +0.7 pts |
| Operating margin | 17.1% | 18.5% | -1.4 pts |
| Net margin | 11.9% | 13.2% | -1.4 pts |
| Free cash flow margin | 27.5% | 19.9% | +7.6 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $150M | $145M | $4.8M | +3% |
| Gross profit | $63.2M | $60.0M | $3.1M | +5% |
| Cost of revenue | $86.4M | $84.7M | $1.7M | +2% |
| Other income, net | $12.7M | −$563K | $13.2M | — |
| Operating profit | $25.5M | $26.8M | −$1.3M | -5% |
| Operating expenses | $37.6M | $33.2M | $4.4M | +13% |
| Pre-tax earnings | $38.2M | $26.2M | $12.0M | +46% |
| Research & development | $6.3M | $4.8M | $1.6M | +33% |
| SG&A | $30.8M | $28.4M | $2.4M | +9% |
| Net earnings | $17.8M | $19.2M | −$1.4M | -7% |
| Income tax | $20.5M | $7.1M | $13.4M | +189% |
| Depreciation & amortization | $8.7M | $8.8M | −$38K | -0.4% |
| Working capital & other | $17.0M | $5.5M | $11.5M | +210% |
| Operating cash flow | $43.5M | $33.4M | $10.1M | +30% |
| Free cash flow (OCF − capex) | $41.1M | $28.9M | $12.3M | +43% |
| Capital expenditures | $2.4M | $4.6M | −$2.2M | -48% |
Questions
How much did CTS's revenue grow quarter over quarter in Q3 2026?
CTS's revenue rose $4.8M (+3%) from $145M in Q2 2026 to $150M in Q3 2026. Gross margin 42.2% against 41.5% (+0.7 pts).